{"nctId":"NCT01044030","briefTitle":"Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children","startDateStruct":{"date":"2010-02"},"conditions":["Acute Otitis Media"],"count":326,"armGroups":[{"label":"Xylitol syrup","type":"EXPERIMENTAL","interventionNames":["Drug: Xylitol syrup"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Xylitol syrup","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Six months to five years of age\n* General good health\n* History of at least three episodes of AOM in previous 12 months, at least one of which occurred within the previous six months\n* English or Spanish speaking\n\nExclusion Criteria:\n\n* History of tympanostomy tubes\n* Intestinal malabsorption or chronic diarrhea\n* Diabetes mellitus\n* Any inborn error of metabolism\n* Parent/guardian unreachable by telephone\n* Known allergy to any of the study solution components (xylitol, sorbitol, sodium carboxymethylcellulose, potato starch, glycerin, potassium sorbate, natural berry flavoring).","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","maximumAge":"5 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Effectiveness of Viscous-adherent Xylitol Syrup in Reducing Episodes of Clinically-diagnosed Acute Otitis Media","description":"Proportion of subjects who remained free of acute otitis media throughout the study period","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.9","spread":null},{"groupId":"OG001","value":"63.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Effectiveness of Viscous-adherent Xylitol in Reducing Antibiotic Use in Children With Recurrent Acute Otitis Media","description":"Proportion of subjects with no antibiotic use during the study period","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.6","spread":null},{"groupId":"OG001","value":"56.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Effect of Viscous-adherent Xylitol on Nasopharyngeal and Oropharyngeal Colonization With Streptococcus Pneumoniae and Nontypeable Haemophilus Influenzae","description":"Proportion of subjects acquiring colonization with Streptococcus pneumoniae and/or nontypeable Haemophilus influenzae among the subset of patients recruited at the local enrolling sites","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.4","spread":null},{"groupId":"OG001","value":"20.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Antimicrobial Resistance Patterns of Isolates of Streptococcus Pneumoniae and Nontypeable Haemophilus Influenzae Cultured From the Oropharynx and/or Nasopharynx of Subjects Treated With Viscous-adherent Xylitol Compared to Placebo.","description":"Proportion of subjects colonized with antibiotic resistant S. pneumonia after treatment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Antimicrobial Resistance Patterns of Isolates of Streptococcus Pneumoniae and Nontypeable Haemophilus Influenzae Cultured From the Oropharynx and/or Nasopharynx of Subjects Treated With Viscous-adherent Xylitol Compared to Placebo.","description":"Proportion of subjects colonized with antibiotic resistant nontypeable H. influenzae after treatment","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":160},"commonTop":["Diarrhea","Upper respiratory tract infection","Flatulence","Abdominal Pain"]}}}